Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04874285
Status:
COMPLETED
Last Update Posted:
2023-11-03
First Post:
2021-05-03
Brief Title:
Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone
Sponsor:
LoLiPharma srl
Organization:
LoLiPharma srl
Study Overview
Official Title:
Supplementation With Hyaluronic Acid Alpha-lipoic Acid Magnesium and Vitamin D and B6 in Patients at Risk of Abortion Treated With Progesterone a Pilot Study
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The trial aims to investigate the effect of supplementation with hyaluronic acid alpha-lipoic acid magnesium vitamin D and vitamin B6 in progesterone-treated pregnant women with risk factors for abortion
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None